Sherry Cefali
Managing Director
Duff & Phelps
Sherry Cefali is a managing director in the Transaction Opinions practice and the head of Duff & Phelps’ Los Angeles office of approximately 100 people. She has been with Duff & Phelps for 30 years, advising companies and boards, rendering fairness opinions and solvency opinions and determining valuations of companies and securities.
Cefali’s transactions in 2020 included a fairness opinion to the board of Neon Therapeutics, Inc. in connection with its sale to BioNTech; a fairness opinion to NN, Inc. in connection with the sale of its Life Sciences business to American Securities; a fairness opinion to the board of Xtant Medical Holdings Inc. in connection with the exchange of $62 million in debt for equity; and a fairness opinion to certain funds affiliated with Blackstone in connection with a recapitalization transaction to sell BioMed Realty for $14.6 billion to a group led by existing BioMed investors; among others.
Return To Index
